The kinetics of entry and release of gentamicin was investigated in fluids and tissues of the inner ear of the rat, as well as in renal cortex, and in organs that do not share susceptibility to the toxic effects of aminoglycosides. Various modes of administration were used to achieve different patterns of drug plasma concentrations. Electrophysiological and histological examinations were performed to correlate pharmacokinetics and ototoxicity.
Introduction
Since the early works of Voldrich (1), Vrabec (2) , and Stupp (3) it has been speculated that the pathogenesis of aminoglycoside ototoxicity is related to the accumulation of the drug in the inner ear fluids; the more ototoxic the aminoglycoside, the longer its retention in the labyrinthine fluids. Subsequent studies (4) (5) (6) (7) (8) (9) (10) (11) (12) apparently supported this theory. We were, however, unable to demonstrate such a phenomenon of accumulation over plasma values in the fluids of the inner ear. In rats receiving a 6-d constant infusion of 15 pg/min of gentamicin, the ratio of perilymph to plasma levels remained low for the duration ofthe experiment, regardless of the drug levels in plasma, which were increasing due to the progressive decline of the glomerular filtration rate; concomitantly, the endolymphatic drug concentraThe majority of this work was performed in the Biochemistry Laboratory of the Kresge Hearing Research Institute.
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Receivedforpublication 22 April 1985 and in revisedform 17 January 1986. tions remained at a steady low value and at a rather constant ratio to the concentrations in perilymph (13, 14) . Similarly, levels ofthe antibiotic in lateral wall and organ of Corti ofguinea-pigs that received chronic parenteral administration of neonycin for up to 3 wk were not higher than levels in nonsusceptible body organs (15) . However, because of the diversity of experimental conditions, the issue ofthe accumulation phenomenon remained debatable.
We, therefore, designed the present study to investigate the kinetics ofentry and release ofgentamicin in both the fluids and the tissues of the inner ear of the rat during various modes of administration. The kinetics of the drug were assessed in the renal cortex, a structure already extensively investigated (16) (17) (18) (19) (20) (21) , simultaneously with organs that do not share susceptibility to the toxic effects of aminoglycosides. Animals were also subjected to electrophysiological and histological examinations in an attempt to correlate pharmacokinetics and ototoxicity.
Results show that: (a) the uptake ofgentamicin by the tissues of the inner ear is dose dependent, manifests rapid saturation kinetics, and leads to a distribution of the drug into different compartments; (b) no accumulation develops either in tissues or in labyrinthine fluids; (c) ototoxicity seems to be related to the penetration ofthe drug into compartment(s) from which the half-life of disappearance is extremely slow; (d) rapid uptake, early saturation, and long exposure of the tissues to the drug may account for the development of toxicity in inner ear and kidney.
Methods

Gentamicin administration
The uptake ofgentamicin was studied in 228 male Sprague-Dawley rats, weighing 200-250 g. The drug was administered by single intramuscular injection (group I) of 10 mg/kg (subgroup Ia, n = 20) or 100 mg/kg body weight (subgroup Ib, n = 20); and by constant infusion (group II) at four different rates: 1.5 pug/min (subgroup Ila, n = 37), 4 .5 pg/min (subgroup Ilb, n = 27), 15 pg/min (subgroup lIc, n = 27), and 150 Ag/min (subgroup lId, n = 23). For The release of the drug after termination of treatment was studied for 10 d in the 40 animals of group I. In 74 animals (group III) release was measured for 30 d after two conditions of drug administration: after a 3-h constant infusion of 15 tg/min (subgroup I11a, n = 34; at the end ofthe infusion period, the plasma concentration ofgentamicin was measured to ensure that infusion had been properly performed) or after a daily injection of100 mg/kg i.m. for 30 consecutive days (subgroupI1Ib, n = 45). In this series, five animals died ofrenal failure during the second or the third week of the treatment period. In the 40 surviving animals, this regimen induced ototoxicity without a marked renal impairment and thus allowed a 30-d follow-up.
Sampling procedures
Samples of endolymph, perilymph, plasma, and various organs were obtained at various times from animals in the different subgroups. In group I, samples were taken at 3, 6, and 24 h as well as on the 5th and 10th days. Additional plasma samples were collected at 30 min and I h to determine peak drug levels. In group II, depending on the infusion rates, samples were taken at times ranging from 30 min to 24 d. In subgroup IIIa, they were collected at the end of the infusion period and then daily during the next 5 d, as well as on the 10th, 15th, 20th, and 30th days. In subgroup I1Ib, the first sampling was made 24 h after the last injection and then at the same intervals as in subgroup Ila.
At the time of sampling, the animal was anesthetized with thiobutabarbital (100 mg/kg), tracheotomized, and maintained at 36.50C on a heating pad. One endolymph sample of about 200 nl/animal was collected from one side, as described previously (13) . The purity of the sample was immediately ensured by measuring the Na and K concentrations in a 25-nl aliquot by flame emission photometry. A 125-nl aliquot ofthe remaining endolymph was withdrawn in a calibrated micropipette and diluted in 50 AI of distilled water. The diluted sample was stored at -30'C. In case of failure to obtain pure endolymph, a second attempt was made on the other ear. Because we had found previously (13) that gentamicin was not detectable in endolymph for 10 h in rats that were given a 15 pg/min constant infusion, endolymph was not sampled before that time in the present study, except in subgroup Ild, i.e., in rats receiving 150 Mg drug/min.
One perilymph sample of about 6 MI/animal was then collected from one cochlea using an external approach to the first coil of the scala vestibuli, as previously described (13). 5 Ml of the sample were drawn into a glass capillary tube (Microcap; Drummond Scientific Co., Broomall, PA) and diluted in 50 Al ofdistilled water. The diluted sample was stored at -30°C. Perilymph, like endolymph, was not sampled before 12 h, except in subgroup Ild, for the reasons described above.
Thereafter, a blood sample of about 300 MI was collected through an indwelling femoral catheter on dry lithium heparinate and the tube was centrifuged for 2 min. A 100-Ml aliquot of plasma was stored at -30°C.
The animal was then exsanguinated through the femoral catheter and perfused with isotonic saline for 5 min to rinse the vascular bed. Samples of heart, liver, lung, spleen, and renal cortex were taken and homogenized with a Polytron (Brinkmann Instruments Co., Westbury, NY) in 0.2 M sodium phosphate, pH 8. The two bullae were removed and the cochlea was rinsed thoroughly with isotonic saline through the windows. The tissues of the lateral wall, i.e., stria vascularis and spiral ligament, and of the organ of Corti were dissected from both ears and pooled separately. Tissues were collected in 0.2 M sodium phosphate, pH 8, and homogenized as previously described (22) . Homogenates were transferred to propylene tubes in which all subsequent manipulations were performed.
The number of data points for individual tissue and conditions may not always correspond to the number of animals in that subgroup, as a few tissue samples were lost during manipulation.
Electrophysiological and histological studies 37 animals (group IV) were studied along with the above groups for electrophysiological and histological assessment of the inner ear. These animals were submitted to the same drug treatment as those subjected to the release study (group III). min. In liver, spleen, and heart, gentamicin could not be detected. In this subgroup, kinetics were not assessed in labyrinthine fluids. After a single injection of 100 mg/kg, gentamicin concentration peaked in plasma at 168±3 ,ug/ml 30 min after the injection. The concentration then decreased rapidly and from the early points, i.e., up to 3 h, a t, of about 39 min was calculated.
The limited number of samples precluded a correct determination of the further phases of disappearance. In the tissues of the inner ear, the concentration at 3 h was 0.06±0.01 jig/mg of protein in both organ of Corti and lateral wall. The concentrations then declined with a tt of 13.3 and 10.6 h in the organ of 10 12 Corti and the lateral wall, respectively. At In perilymph, the concentrations seemed to be related to the infusion rates (Fig. 3) . For the duration of the experiments and for all subgroups, the perilymph to plasma ratios of gentamicin concentrations ranged from 0.05 to 0.24. When considering all the perilymph samples collected at 12 h, a linear relationship was observed between the mean perilymph concentration and the plasma level for all infusion rates ranging from 1.5 to 150
,gg/min (y = 0.029x + 0.32, r = 0.99, P < 0.001).
In endolymph (Fig. 4) , results showed that: (a) the higher the infusion rate, the earlier the detection ofthe drug. Gentamicin was detected at 6 h in subgroup d (although one sample showed a detectable amount at 1 h), at In renal cortex, the kinetics were similar to that observed in inner ear tissues. The saturation levels in subgroups c and d, however, were not achieved until 24 h and then reached a value 10-fold higher than in the cochlea, i.e., about 10 Group III (release). In the 34 animals of subgroup lIla, the release of gentamicin was studied for 30 d after the end of a 3-h infusion of 15 jg/min (Table I ). In plasma, the concentrations were 11.8±1.2 jg/ml at the cessation of the infusion and 0.16±0.03 ug/ml at 24 h, indicating a rapid decline compatible with that observed in group I. The rest of the plasma curve appeared to be biexponential, and when the points were analyzed according to a bicompartmental model, two phases were determined with half-lives (days) of 1 (r = 0.59) and 16.9 (r = 0.534), respectively. In all organs but the inner ear, the curves were assumed to be monoexponential. According to this assumption, the half-lives (days) were: 5.6 in renal cortex (r = 0.945), 4 .4 in liver (r = 0.934), 3.9 in heart (r = 0.899), 6 .6 in lung (r = 0.797), and 4.6 in spleen (r = 0.729). In cochlear tissues (Fig. 5) In the 40 animals of subgroup IIIb, the disappearance of gentamicin was studied for 30 d after 30 d of a daily 100 mg/ kg i.m. injection. In plasma, the curves were best fitted according to a bicompartmental model and two phases were determined with half-lives (days) of 2.0 (r = 0.587) and 17.5 (r = 0.594), respectively. In all organs, the release seemed to be monoexponential. According to this assumption, the half-lives (days) were 14.5 in renal cortex (r = 0.778), 10.7 in liver (r = 0.932), 14 .2 in heart (r = 0.779), 18.2 in lung (r = 0.794), 24.1 in spleen (r = 0.635), 34 .6 in organ of Corti (r = 0.597), and 38 in lateral wall (r = 0.789).
In both subgroups, the disappearance of gentamicin from perilymph exhibited a similar pattern. In subgroups a and b, the initial values were 0.12±0.04 and 0.15±0.06 Ag/ml, and the final ones at day 30, 0.06±0.01 and 0.18±0.08 gg/ml, respectively.
In subgroup I11a, as expected, no gentamicin was present in endolymph at day 0, i.e., at the end of the 3-h infusion period. In the five following days, however, the drug was detected in all but four samples. Levels were 1.7±0.9 gg/ml at day 1, and 0.37±0.02 ,ug/ml at day 5. Thereafter gentamicin was undectectable. In subgroup IlIb the drug was undetectable in about half the samples. In the remaining samples the concentrations ranged from 0.38 to 3 ,ug/ml over 30 d.
Electrolytes, protein, and BUN measurements
The concentration of K in endolymph was 151.3±4.5 mM (n = 142) and the concentration of Na was always lower than the detection limit.
The (Fig. 6) . Latencies, amplitudes, and thresholds exhibited negligible individual variations (P > 0.5).
However, animals injected daily for 30 d (subgroup lVb)
showed significant changes as compared with control animals. As a result ofthe well known delay in action of aminoglycosides, amplitudes continued to decrease after the end of injections (P < 0.001 for all waves). Thresholds elevated progressively from the second month, with no responses being elicited at 78 dB SPL at the end of the evaluations (Fig. 6 ). Conversely, controls had obvious responses at 10±7 dB SPL (P < 0.0001). Finally, latencies progressively lengthened in treated animals from the middle of the second month of the experiment. Differences to controls were evident on the last recording for all waves (P < 0.01). This pattern of pathology was confirmed in the histological study. Subgroups IVa, IVc, and IVd exhibited normal cytocochleograms (Fig. 7, right) . Scattered missing hair cells were within the range of controls, as were apical alterations. Furthermore, electron microscopic evaluation failed to detect any abnormality related to aminoglycoside ototoxicity. Envelopes, cytoplasms, nuclei, and nerve endings looked normal. In contrast, rats given 100 mg of gentamicin daily for 30 d (subgroup IVb) had widespread hair cell losses, predominantly in the third row of outer hair cells (Fig. 7, left) , although some variations in pattern existed. Amid spared cells, all stages of aminoglycoside-induced damage, ranging from irregularities in the smooth endoplasmic reticulum or damaged mitochondria to massive swelling with rupture at the cuticular pore, were observed with an electron microscope.
It was concluded that neither a single injection of 100 mg/ kg i.m. nor continuous 3-h infusion with 15 lsg/min gentamicin seemed to influence either electrical activity or anatomical structure ofthe cochlea. In contrast, daily injections of 100 mg/ kg gentamicin for 30 d induced typical signs of ototoxicity.
Discussion
From the experiments with continuous infusion, it appeared that the uptake of gentamicin into the tissues of the inner ear proceeded by a mechanism which yielded early steady state levels and manifested rapid saturation kinetics. For low infusion rates, and as long as no renal failure developed, tissue levels seemed to be related to plasma levels, suggesting that the uptake of the drug by the tissues of the inner ear was concentration dependent and, thus, dose dependent. This would agree with the kinetics of aminoglycosides in kidney where the fractional absorption is constant within a given range of filtered load (28) . For infusion rates yielding plasma concentrations of 5Sug/ml and more, tissue concentrations plateaued, suggesting that a saturation had occurred. The low ratio of the perilymph and endolymph to plasma concentrations throughout the duration of the experiment, along with the saturation in the tissues at relatively low drug levels, strongly argue against the concept of an unrestricted accumulation ofthe drug in the inner ear, which has long been considered (3, 6, 9, 29) a basic mechanism of the organ specificity of aminoglycoside toxicity.
The polycationic aminoglycosides have been shown to bind to anionic sites of membranes such as acidic phospholipids, and to possess a particularly high affinity to polyphosphoinositides considered to be present in the inner leaflet of the plasma membrane (30-33). Recent experiments of gentamicin toxicity in cochlear perfusions have also suggested that, as in the kidney (34-37), the drug may be taken up into the cell by an active transport mechanism (38) . The rapid uptake observed in the present study agrees with a strong affinity of gentamicin for its cellular binding sites; the early saturation could be the conse- Figure 6 . Comparison with the kinetics in other body organs provides the following information. First, in renal cortex, the kinetics of drug uptake is similar to that of the inner ear tissues and saturation is also observed. However, the concentrations achieved are higher than in the inner ear by one order of magnitude. Such a discrepancy between two organs that demonstrate a similar susceptibility to gentamicin remains difficult to elucidate. In the kidney, high drug concentrations are found in the lysosomes of proximal tubular cells (34-37) but no information is available on the cellular or subcellular distribution in the inner ear. The present study only analyzed the major tissues of the cochlea, and the technical limitations'of the autoradiographic investigations performed so far (39-41) preclude a precise mapping of the cochlear structures with regard to the location of the drug. Accordingly, no conclusion can be drawn as to whether the levels of aminoglycoside concentrations achieved in a given cell type may be directly related to the development of toxicity.
Second, in other organs, the scatter of the data precluded definite conclusions. In addition, results from spleen must be considered with caution since the possibility of contamination with blood cannot be disregarded. In liver or heart, the concentrations plateaued at values which increased as a function of infusion rates, suggesting that the uptake of the drug is concentration dependent. In contrast to inner ear and kidney, however, the rate of uptake was markedly slow, suggesting a poor affinity of gentamicin for the binding sites of these organs, and no saturation could be demonstrated within the duration of the experiment.
The release of the drug from the tissues of the inner ear was measured to determine whether the pattern of disappearance differed depending on the duration of drug treatment and on the presence or absence of ototoxicity. Accordingly, the elimination kinetics were studied after three ways of loading, yielding either high but brief peak plasma levels (group I); early saturation levels in the tissues, but no functional impairment (subgroup Ina); or persistent saturation levels with electrophysiological and histological evidences of toxicity ( The present study demonstrates that drug concentrations in the labyrinthine fluids do not directly correlate to those in cochlear tissues, and, therefore, cannot represent any index oftoxicity as it has previously been postulated (3, 6) . It also suggests that perilymph, probably via cortilymph (57) , is the main route of access for the aminoglycosides to the sensory structures. While the organ of Corti is saturated in 3 h, gentamicin is not yet detectable in endolymph regardless of the infusion rates. The present data also confirm our previous findings (13, 14) that: (a) neither an accumulation nor a threshold for drug entry exists for perilymph, (b) the perilymphatic concentrations are related to plasma concentrations whatever the infusion rate, (c) gentamicin appears in endolymph later than in perilymph, and (d) the persistence of the drug in both fluids after cessation of the administration is probably due to the slow release of the drug from the tissues toward the surrounding fluids.
Comparison of the kinetic data obtained from the different organs shows that rapid uptake, early saturation, and long exposure to the drug are features that occur exclusively in renal and cochlear structures and may account for the development of toxicity. In the inner ear, the surrounding fluids maintain sustained concentration levels of gentamicin in the vicinity of the sensory structures. The rapidity of this uptake, which leads to fast saturation, provides more time for the drug to reach deep compartment(s). This penetration may be related to the expression of noxious effects. Finally, the extremely slow half-life of disappearance from the inner ear tissues demonstrates the very particular handling of gentamicin by the cochlear cells, yielding an almost permanent sequestration of the drug.
